A case report of gastroduodenal intussusception caused by gastric gastrointestinal stromal tumor Authors: Congpu Wen, Shengwei Ji, Maowei Pei, Lili Jin Published: 2026 ABSTRACT IntroductionIntussusception is most commonly seen in children and is relatively rare among adults. While it can occur anywhere in the gastrointestinal tract, gastroduodenal intussusception resulting from gastrointestinal stromal tumors (GIST) is a rare clinical finding.Case presentationHere we report a case of gastroduodenal intussusception caused by gastric GIST in a 68-year-old female. She sought medical attention for symptoms including nausea, recurrent vomiting of blood, and epigastric pain. Plain computed tomography (CT) scan revealed a well-defined mass located on the gastric fundus, which was confirmed intraoperatively. Endoscopy demonstrated that the mass had prolapsed into the duodenum. Based on these findings, gastroduodenal intussusception secondary to a gastric tumor was diagnosed. The patient underwent successful partial gastric resection, which confirmed a mass originating from the gastric fundus and prolapsing into the duodenum. The postoperative pathological diagnosis was low-risk gastric GIST according to the National Institutes of Health (NIH) criteria. The patient was followed up for 12 months, undergoing CT imaging at 6 months and both CT and gastroscopy at 12 months, with no evidence of tumor recurrence.ConclusionGastric GISTs are a rare but clinically significant cause of adult gastroduodenal intussusception, typically necessitating surgical intervention. Multimodal imaging, particularly CT, plays a crucial role in preoperative diagnosis, while histopathological examination remains essential for definitive diagnosis and risk stratification. Treatment should be individualized based on tumor size, location, and patient factors. Introduction Gastroduodenal intussusception is an extremely rare event in adults. The etiologies primarily include gastric tumors such as gastrointestinal stromal tumors (GISTs), carcinoma, lipoma, schwannoma, and leiomyoma according to literatures (1). A comprehensive literature review by Hsieh et al. (2) covering the past two decades identified gastric GIST as the predominant cause, accounting for over half of reported adult cases. Here, we report a case of gastroduodenal intussusception caused by endophytic gastric GIST in a 68-year-old female. We discuss the clinical manifestations, diagnosis, management, and prognosis in the current case within the context of existing literature. A summary of previously reported cases is provided in Table 1 to contextualize our findings. Table 1Summary the clinical characteristics of gastroduodenal intussusception caused by GIST in PubMed.Case no.AuthorsDate of publishingCountryAge (year)GenderClinical symptomsTumor locationTumor size (cm)Imaging testTreatment1Siam et al. (3)2008Malaysia29MAbdominal pain and anaemia, nausea and vomiting,Antrum6×6EGDLaparotomy; Partial gastrectomy(Bilroth’s I)2Chan et al (4)2009China34FEpigastric painFundus6.5×4.4CT; EGDLaparoscopic; wedge resection3Gyedu et al. (5)2011Ghana59FIntermittent vomitingAnterior wall7×6CT; USLaparotomy; wedge resection4Costi et al. (6)2011France81MAbdominal pain and anemiaPosterior wall4×3CT; EGDlaparoscopic; Atypical gastrectomy5Seok et al. (7)2012Korea51MNausea, vomiting, melena and severe anemiaAntrum5.5×4.2×1.7EGD; CTLaparotomy; Partial gastrectomy6Wilson et al. (8)2012Ireland78FEpigastric discomfort, vomiting and anorexiaDistal body andantrumc4.4×3.3×3.4CT; EGDEndoscopic and laparoscopic; wedge resection7Rittenhouse et al. (9)2013USA52FEpigastric pain, vomitingFundus5×5CT; EGD; USLaparoscopic; wedge resection8Anania et al (10)2013Italy63FEpigastric discomfort, dyspepsia and bilious vomitingFundus19×11×9CT; EGD; USLaparoscopic; wedge resection9Babannavar MSPB et al (11)2015India74MVomitingPosterior wallEGD; CECTLaparotomy; wedge resection10Yildiz et al (12)2016Turkey85FEpigastric discomfort, nausea, vomiting and weight lossFundus6×5CECT; USLaparotomy,subtotal gastrectomy and Roux and Y anastomosis11Komatsubara et al. (13)2016Japan90FvomitingBody5×4.5×4EGD; CTLaparotomy, wedge resection12Jameel et al (14)2017India65FEpigastric pain, vomitingPosterior wall6×6×4EGD; CTLaparotomy, wedge resection13Yamauchi et al (15)2017Japan95Fvomiting and melenaPosterior wall4.2×3.9CT; EUSEndoscopic; ESD14Zhou et al (16)2018China69MAbdominal pain, nausea and vomitingAntrum4.5×4EGD; CTLaparoscopic; wedge resection15Ssentongo et al. (17)2018Ghana85FEpigastric pain dyspepsiaFundus2.5×2.5CTLaparotomy, wedge resection16De et al. (18)2018India42FEpigastric pain and vomitingAnterior wall8×7×4EGD; CTLaparotomy, wedge resection17Đokić et al. (19)2019Slovenia62MVomiting, weight lossBody7.5×5.5×4CECT; USLaparotomy, wedge resection18Mohammed AA et al. (20)2019Iraq65FVomiting, weight lossBody45×21EGD and biopsy; CTLaparotomy, Total gastrectomy, roux-en-y esophago-jejunostomy and jejunojejunostomy19Michael et al. (21)2021Uganda23FEpigastric pain, vomitingBody6×7CECT; EGDLaparotomy; wedge resection20Arora E et al. (22)2021India36MAnemia, and melenaBody9.5×8.5×7.5CT; EGDLaparoscopic; wedge resection21Hsieh YL et al (2)2021China84FPostprandial fullness with nausea and vomitingBody5.9EGD; CTEndoscopic; ESD22Numpraphrut P et al. (23)2022Thailand55MEpigastric pain and vomitingFundus5.5×4.3×4CT; EGD; EULaparoscopic; wedge resection23Zhang W et al (1)2022China85MBlack stools; epigastric discomfortBody and antrum5×3.5EGD; CTlaparoscopic exploration; Laparotomy; wedge resection24Nicola S et al (24)2022Italy36MMelena and severe anaemiaFundus11×4EGD; CTLaparotomy; wedge resection25Singh K et al (25)2023USA72abdominal pain, nausea and vomitingBody5.6×5.3EGD and biopsy; CTEndoscopic(Failure), Laparotomy, distal antrectomy (Billroth II)26Tagliaferri A R et al (26)2023USA85Mabdominal painBody5.6×5.3EGD; CTLaparotomy; Distal gastrectomy (Billroth II)27Mujaheed Suleman et al (27)2024Tanzania75Fabdominal pain, weight lossFundus6x6CTLaparotomy, wedge resection28Our case2024China68FVomiting bloodFundus5×4×3EGD; CTLaparotomy; wedge resection Summary the clinical characteristics of gastroduodenal intussusception caused by GIST in PubMed. Case description A 68-year-old female was admitted to the Gastroenterology Department with a 1-day history of nausea, recurrent hematemesis, and epigastric pain. She had comorbidities of hypertension (amlodipine 5mg daily), cerebral infarction (aspirin 100mg daily), diabetes (metformin 0.5g thrice daily), and intermittent celecoxib use for gallstone-related pain. Physical examination showed signs of anemia, and a soft abdomen without guarding, rebound tenderness, or palpable masses. Notably, the patient had right limb muscle strength grade 0 (left grade V-). This profound weakness was a long-standing sequela of a prior cerebral infarction that had resulted in persistent right-sided hemiplegia. No other focal neurological deficits were present, and this finding did not directly impact the gastrointestinal presentation but was relevant for perioperative mobility and rehabilitation planning. Laboratory tests revealed severe anemia (hemoglobin 52 g/L, hematocrit 0.157), leukocytosis (9.99×109/L), and normal CEA, Ca 19–9. Abdominal computed tomography (CT) scan demonstrated a well-defined, intraluminal, heterogeneous mass measuring 5.4×4.8×4.2 cm located at the gastric fundus (Figure 1). The mass exhibited soft-tissue density with focal hyperdense areas suggestive of intratumoral hemorrhage, correlating with the patient’s history of hematemesis. No definite signs of intussusception (such as the “target sign” or bowel wall thickening) were seen on CT, but the mass abutted the pylorus. There was no evidence of lymphadenopathy, ascites, or distant metastases. Intraluminal tumor in the gastric funds on CT. Axial (a) and coronal (b) CT images reveal an intraluminal gastric fundus tumor with well-defined borders (arrow). Gastroscopy confirmed a gastric fundus mucosal uplift, with the tumor prolapsing through the pylorus into the duodenal bulb, causing gastroduodenal intussusception and gastric outlet obstruction. Endoscopic reduction was attempted but was unsuccessful (Figure 2). Endoscopic ultrasound (EUS) was not performed because the patient presented with active hematemesis and hemodynamic instability, requiring urgent surgical consultation. Moreover, the diagnosis of intussusception secondary to a gastric tumor was already strongly suggested by the combination of CT and gastroscopy, and EUS would not have altered the urgent need for surgical resection. Endoscopic appearance of the gastric mass. Gastroscopy shows mucosal uplifting of the gastric fundus; the tumor caused invagination of the gastric cardia through the antrum and pylorus into the duodenum, resulting in gastric outlet obstruction. The patient was transferred for surgery. Diagnostic laparoscopy was converted to laparotomy, revealing a pylorus-impacted gastric mass without abdominal dissemination. R0 radical resection with wide margins was performed after intussusception reduction, and the gastric wall defect was transversely sutured in two layers (no tumor rupture). Postoperative histopathology showed a 5×4×3 cm epithelioid tumor (Figure 3) with 2 mitoses/50 high-power fields (HPFs) (Figure 4). Immunohistochemistry (IHC) was positive for CD34, DOG-1, CD117, Vimentin, Ki-67 (≈3%), and P53 (Figure 5). According to the National Institutes of Health (NIH) consensus criteria for GIST risk stratification (based on tumor size, mitotic count, and anatomical site), the tumor was classified as low−risk (size 5 cm, mitoses 2/50 HPFs, gastric origin). The pathological diagnosis was low-risk epithelioid gastric GIST with intratumoral bleeding. The final clinical diagnosis was gastroduodenal intussusception secondary to gastric GIST. Macroscopic specimen of the excised tumor. The macroscopic resection specimen measures 5 cm × 4 cm × 3 cm and displays hemorrhage spots, cystic changes, and necrotic areas. Histological features. (a) HE staining (×100) shows a tumor with a visible capsule, hemorrhage area, fasciculate cellular arrangement, and myxoid changes. (b) HE staining (×400) reveals fusiform to epithelioid tumor cells with hyperchromatic nuclei, uneven chromatin distribution, karyorrhexis, and mitotic figures. HE, Hematoxylin–Eosin. Immunohistochemical features. (a) IHC for CD117 (×100) demonstrates strong positivity with clear cell changes. (b) IHC for CD34 (×100) shows intense staining in epithelioid tumor cells. CD, cluster of differentiation; IHC, immunohistochemistry. The patient recovered well and was discharged on postoperative day 8. She was followed up for 12 months, undergoing contrast-enhanced CT at 6 months and both contrast-enhanced CT and gastroscopy at 12 months; no evidence of tumor recurrence or metastasis was observed. Discussion This report presents a case of adult gastroduodenal intussusception caused by a gastric GIST. The clinical validity and methodological accuracy are well-supported by the clear correlation between preoperative findings, surgical observations, and definitive pathology. Preoperative CT and endoscopic findings of an intraluminal mass causing intussusception were directly confirmed during laparotomy. Histopathological analysis confirmed a low-risk epithelioid GIST. The diagnosis was solidified by characteristic immunohistochemistry (CD117+, DOG-1+, CD34+) and low proliferative activity (mitotic count 2/50 HPF, Ki-67 ~3%), fulfilling standard diagnostic criteria. The tumor was classified as low−risk according to the NIH criteria. The consistency between clinical manifestations (gastrointestinal bleeding, anemia, obstruction), imaging, surgical findings, and histopathology ensures the accuracy and internal validity of the case. The principal unique aspect of this case is the etiology of the intussusception. Adult gastroduodenal intussusception is an extreme rarity, and a GIST acting as the lead point is a seldom-reported cause, with fewer than 30 documented instances in the medical literature (5). Clinically, it diverged from the typical indolent course of many GISTs by presenting as an acute surgical emergency with upper gastrointestinal bleeding and obstruction. A notable feature was the intermittent nature of the symptoms, suggesting episodes of spontaneous reduction and recurrence of the intussusception—a dynamic process rarely elaborated in previous reports. Furthermore, the patient’s multiple comorbidities added significant complexity to perioperative management. Two interlinked hypotheses can explain the observed clinical and anatomical findings. First, GISTs originate from the interstitial cells of Cajal, the gut’s pacemaker cells. As this epithelioid GIST grew to a substantial size (exceeding 5 cm), it formed a well-defined, intraluminal lead point. Normal gastric peristalsis likely exerted traction on this mass, progressively telescoping the gastric wall through the pylorus into the duodenum. This is supported by the intraoperative finding of the tumor protruding into the duodenum and the classic “target sign” on imaging. The tumor’s low-risk biology (low mitotic rate, well-defined borders) allowed it to achieve this size without prior metastasis or rupture. Second, the “intermittent reducibility hypothesis” accounts for the patient’s fluctuating symptoms (intermittent epigastric pain, recurrent vomiting). Unlike irreversible intussusception seen in children, adult intussusception secondary to GISTs may be transient. Variations in peristaltic force and gut wall elasticity could allow for spontaneous reduction, leading to temporary symptom relief, followed by recurrence. This cyclical pattern explains the patient’s episodic pain and vomiting and is consistent with the absence of peritoneal signs or clear ischemia on exam. This intermittent nature can significantly delay diagnosis, as symptoms mimic more common, transient gastrointestinal disorders. The patient’s severe anemia likely resulted from acute bleeding from ulcerated and necrotic tumor surface mucosa. This ulceration occurs when tumor growth outpaces its blood supply. The tumor’s vascular nature, evidenced by strong CD34 positivity, may have exacerbated the bleeding once the mucosal barrier was breached. This case offers several critical lessons for diagnosing and managing rare gastrointestinal presentations. In terms of diagnosis, this case emphasizes the necessity of considering GIST-induced intussusception in adults with upper gastrointestinal symptoms, particularly episodic pain or vomiting accompanied by anemia or bleeding. Given the non-specific clinical manifestations, clinicians should avoid misdiagnosing such cases as common gastrointestinal disorders. CT (6)should be the first-line investigation due to its ability to visualize the characteristic signs of intussusception (e.g., target sign, sausage-shaped mass) and to evaluate tumor size, location, and anatomical relationships. In the present case, although plain CT did not definitively show the intussusception, it clearly identified the gastric fundus mass with features of intratumoral hemorrhage, guiding further endoscopic evaluation. While endoscopy directly visualizes the intraluminal mass and can identify surface ulceration, it may miss submucosal lesions. Endoscopic ultrasound (EUS) is highly valuable in such scenarios, providing detailed anatomical layering and enabling fine-needle aspiration (FNA) (7) for a definitive tissue diagnosis before surgery. However, in acutely unstable patients with active bleeding, as in our case, EUS may be deferred in favor of prompt surgical intervention. This multimodal approach can reduce diagnostic delays, which are common in rare diseases and may lead to adverse outcomes. In terms of management, surgical resection remains the gold standard for GIST-induced intussusception, particularly when endoscopic reduction fails. The surgical goal is complete resection with wide negative margins (R0 resection) to minimize recurrence risk, while avoiding tumor capsule rupture. For low-risk GISTs, a limited resection without routine lymphadenectomy is adequate. The choice of approach (1)—open, laparoscopic, or robotic—should be tailored based on tumor size, location, and surgical expertise. This case also highlights the imperative of tailored perioperative care for patients with significant comorbidities, requiring a coordinated multidisciplinary team to manage coexisting conditions like hypertension, diabetes, and prior stroke. In terms of follow-up and prognosis, the case confirms that low-risk epithelioid GISTs have a favorable prognosis with no recurrence or metastasis observed within 12 months of follow-up. Our follow-up protocol included contrast-enhanced CT at 6 months and combined contrast-enhanced CT and gastroscopy at 12 months. This supports current guideline-based follow-up protocols, typically involving periodic imaging (e.g., CT every 6–12 months) for several years. Accurate histopathological and immunohistochemical (8) analysis is paramount for risk stratification, based on size, mitotic rate, and tumor location, remains crucial for guiding therapy, including the use of adjuvant imatinib for higher-risk tumors. For these rare cases of intussusception, long-term follow-up data remain scarce, emphasizing the need for continued reporting to better understand long-term outcomes. In summary, this case highlights the value of case reporting for rare diseases. It reinforces key clinical principles: maintaining a high index of suspicion for unusual etiologies of common symptoms, employing a systematic multimodal diagnostic approach, adhering to oncologically sound surgical principles, and tailoring management to individual patient comorbidities. A summary of previously published cases (Table 1) further strengthens the evidence base. Future research should focus on conducting a systematic review and meta-analysis of all reported cases to identify common clinical features, optimal diagnostic modalities, and best surgical practices for this rare condition.